Literature DB >> 25689481

Targeting and function of proteins mediating translation initiation in organelles of Plasmodium falciparum.

Afreen Haider1, Stacey M Allen2, Katherine E Jackson2, Stuart A Ralph2, Saman Habib1.   

Abstract

The malaria parasite Plasmodium falciparum has two translationally active organelles - the apicoplast and mitochondrion, which import nuclear-encoded translation factors to mediate protein synthesis. Initiation of translation is a complex step wherein initiation factors (IFs) act in a regulated manner to form an initiation complex. We identified putative organellar IFs and investigated the targeting, structure and function of IF1, IF2 and IF3 homologues encoded by the parasite nuclear genome. A single PfIF1 is targeted to the apicoplast. Apart from its critical ribosomal interactions, PfIF1 also exhibited nucleic-acid binding and melting activities and mediated transcription anti-termination. This suggests a prominent ancillary function for PfIF1 in destabilisation of DNA and RNA hairpin loops encountered during transcription and translation of the A+T rich apicoplast genome. Of the three putative IF2 homologues, only one (PfIF2a) was an organellar protein with mitochondrial localisation. We additionally identified an IF3 (PfIF3a) that localised exclusively to the mitochondrion and another protein, PfIF3b, that was apicoplast targeted. PfIF3a exhibited ribosome anti-association activity, and monosome splitting by PfIF3a was enhanced by ribosome recycling factor (PfRRF2) and PfEF-G(Mit). These results fill a gap in our understanding of organellar translation in Plasmodium, which is the site of action of several anti-malarial compounds.
© 2015 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25689481     DOI: 10.1111/mmi.12972

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  8 in total

1.  Insights into the evolution and drug susceptibility of Babesia duncani from the sequence of its mitochondrial and apicoplast genomes.

Authors:  Azan Z Virji; Jose Thekkiniath; Wenxiu Ma; Lauren Lawres; James Knight; Andrea Swei; Karine Le Roch; Choukri Ben Mamoun
Journal:  Int J Parasitol       Date:  2018-08-31       Impact factor: 3.981

2.  Validation of Putative Apicoplast-Targeting Drugs Using a Chemical Supplementation Assay in Cultured Human Malaria Parasites.

Authors:  Geoffrey Ian McFadden; Christopher Dean Goodman; Taher Uddin
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

3.  Characterization of Precursor PfHsp60 in Plasmodium falciparum Cytosol during Its Asexual Development in Human Erythrocytes.

Authors:  P Padma Priya; Manish Grover; Utpal S Tatu; Vasant Natarajan
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

Review 4.  Translational regulation in blood stages of the malaria parasite Plasmodium spp.: systems-wide studies pave the way.

Authors:  Shruthi Sridhar Vembar; Dorothea Droll; Artur Scherf
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-05-26       Impact factor: 9.957

5.  QSAR based predictive modeling for anti-malarial molecules.

Authors:  Deepak R Bharti; Andrew M Lynn
Journal:  Bioinformation       Date:  2017-05-31

6.  Discovering Putative Prion-Like Proteins in Plasmodium falciparum: A Computational and Experimental Analysis.

Authors:  Irantzu Pallarès; Natalia S de Groot; Valentín Iglesias; Ricardo Sant'Anna; Arnau Biosca; Xavier Fernàndez-Busquets; Salvador Ventura
Journal:  Front Microbiol       Date:  2018-08-07       Impact factor: 5.640

7.  Transcriptional changes in Plasmodium falciparum upon conditional knock down of mitochondrial ribosomal proteins RSM22 and L23.

Authors:  Swati Dass; Michael W Mather; Joanne M Morrisey; Liqin Ling; Akhil B Vaidya; Hangjun Ke
Journal:  PLoS One       Date:  2022-10-06       Impact factor: 3.752

Review 8.  Anti-malarial Drug Design by Targeting Apicoplasts: New Perspectives.

Authors:  Avinaba Mukherjee; Gobinda Chandra Sadhukhan
Journal:  J Pharmacopuncture       Date:  2016-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.